Human trials for a universal COVID vaccine are set to start later this year. While existing vaccines like Pfizer and Astra-Zeneca were developed in record time and are performing well, they may lose effectiveness as the virus mutates, or as new coronaviruses develop.
A universal vaccine would be able to target a fundamental region of the virus that does not change across mutations.